Journal of Surgical Education
Volume 64, Issue 1 , Pages 41-45, January 2007

Comparison of Pleurodesis by Erythromycin, Talc, Doxycycline, and Diazepam in a Rabbit Model

Presented at CHEST 2002, San Diego, California. Presented at the Society of Air Force Clinical Surgeons, San Antonio, Texas, April 2003.

    Maj
  • Quintessa Miller, USAF, MC

      Affiliations

    • Department of Surgery, Wright State University School of Medicine, Dayton, Ohio
    • Corresponding Author InformationCorrespondence: Inquiries to Major Quintessa Miller, MD, Department of Surgery, Wright State University School of Medicine, Suite 7000, Miami Valley Hospital, One Wyoming Street, Dayton, OH 45409
  • ,
  • Carol Meschter, DVM

      Affiliations

    • Veterinary Pathology, Comparative Biosciences, Inc., Mountain View, California
  • ,
  • Terry Neumaster, MD

      Affiliations

    • General Surgery, Department of Veteran’s Affairs, Biloxi, Mississippi
  • , Lt Col
  • Jerry Pratt, USAF, MC

      Affiliations

    • Department of Cardiothoracic Surgery, Keesler Medical Center, Biloxi, Mississippi
  • , Lt Col
  • Michael Moulton, USAF, MC

      Affiliations

    • Department of Cardiothoracic Surgery, Keesler Medical Center, Biloxi, Mississippi
  • , Capt
  • Douglas Downey, USAF, MC

      Affiliations

    • Department of Surgery, Wright State University School of Medicine, Dayton, Ohio
  • , Maj
  • Joseph Harre, USAF, MC

      Affiliations

    • Armed Forces Radiobiology Research Institute, Bethesda, Maryland

Background

Patients with malignant pleural effusion, recurrent spontaneous pneumothorax, and recurrent benign pleural effusions may have significant relief of their symptoms with chemical pleurodesis. Talc is the most frequently used chemical sclerosant; however, it has been known to induce Adult Respiratory Distress Syndrome (ARDS). Other agents such as doxycycline and erythromycin have documented efficacy as sclerosing agents in the pleura, but they are not in widespread clinical use and have significant documented adverse reactions. Diazepam may represent a potential sclerosing agent in the pleura, because of its local inflammatory profile in other tissues.

Materials and methods

Overall, 33 adult New Zealand White rabbits (Oryctolagus cuniculus) were randomized to 5 treatment groups. Each group received an intrapleural injection via 5 Fr silastic tubes of one of the following agents: 35-mg/kg erythromycin in 2 ml of saline, 70-mg/kg talc in 2 ml of saline, 10-mg/kg doxycycline in 2 ml of saline, 0.4-mg/kg diazepam in 2 ml of saline, or 2 ml of saline as a control. The animals were euthanized and necropsied 30 days after injection. The pleural surfaces were assessed for macroscopic and microscopic evidence of surrounding inflammation and fibrosis.

Results

Doxycycline resulted in severe pleural inflammation and fibrosis with pulmonary hemorrhage, whereas talc-treated animals had less effective fibrosis and granulomas. A trend toward higher mortality occurred in doxycycline-treated animals. Erythromycin demonstrated similar fibrosis (p = 0.487) to doxycycline and had less inflammation (p < 0.001). Diazepam treatment had little effect in the pleural cavity.

Conclusions

This study demonstrates that erythromycin may be the ideal sclerosing agent. It had the advantage of maximal fibrosis with minimal inflammation. Although doxycycline was the most potent pleural sclerosant, it caused severe local tissue damage. Talc treatment resulted in only mild fibrosis, and diazepam was ineffective.

Key words: pleural effusion, erythromycin, pleurodesis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0149-7944(06)00129-2

doi:10.1016/j.cursur.2006.07.006

Journal of Surgical Education
Volume 64, Issue 1 , Pages 41-45, January 2007